Granholm Anders A - OmicsDI

Browse
Submit Data
Databases
API

2 Results

Show all Save search Copy query

Show results for

Proteomics (2)

Organisms

Andropogon gerardi (2)
Bacteria (2)
Canis lupus familiaris (2)
Cnidaria (2)
Cricetulus griseus (2)
Eukaryota (2)
Fasciola (2)
Hepatitis B virus (2)
Human betaherpesvirus 5 (2)
Madurella mycetomatis (2)
Mesocricetus auratus (2)
Miscanthus x giganteus (2)
Mus musculus (2)
Mycobacterium tuberculosis (2)
Orthoflavivirus (2)
Panicum virgatum (2)
Platyhelminthes (2)
Pseudomonas aeruginosa AES-1R (2)
Rattus norvegicus (2)
Rattus rattus (2)
Rhodococcus jostii RHA1 (2)
Saccharomyces cerevisiae (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Shigella (2)
Sorghastrum nutans (2)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (2)
Streptococcus pneumoniae (2)
Streptomyces coelicolor A3(2) (2)
Toxoplasma gondii (2)
Tripsacum dactyloides (2)

Repository

pride (2)

Tissue

B cell (2)
B-cell chronic lymphocytic leukemia cell (2)

Disease

Chronic lymphocytic leukemia (2)

Technology Type

Mass Spectrometry (2)
Shotgun proteomics (2)

Publication Date

2024 (1)
2022 (1)

Lab affiliation

Department of Oncology-Pathology, Karolinska Institutet and Science for Life Laboratory (1)
Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

10

Proteogenomic subtyping of chronic lymphocytic leukemia identifies subgroups with contrasting clinical outcome and distinct ex-vivo drug response profile

We have performed a comprehensive proteomic analysis of clinical patient samples of chronic lymphocytic leukemia (CLL) alongside genome-, transcriptome- and ex-vivo drug response profiling. Trisomy 12 and IGHV mutation status had the strongest impact on the proteome and transcriptome; and SF3B1 muta...

ORGANISM(S): Homo sapiens (Human)

2024-06-21 | PXD017453 | Pride

Lymphoblast B-cell Chronic lymphoblastic leukemia Proteogenomics Human Lc-ms Leukemia Cancer Clinical samples. Hirief Proteomics

Proteogenomic subtyping of chronic lymphocytic leukemia identifies subgroups with contrasting clinical outcome and distinct ex-vivo drug response profile

We have performed a comprehensive proteomic analysis of clinical patient samples of chronic lymphocytic leukemia (CLL) alongside genome-, transcriptome- and ex-vivo drug response profiling. Trisomy 12 and IGHV mutation status had the strongest impact on the proteome and transcriptome; and SF3B1 muta...

ORGANISM(S): Homo sapiens (Human)

2022-10-17 | PXD028936 | Pride

Lymphoblast B-cell Chronic lymphoblastic leukemia Proteogenomics Human Lc-ms Leukemia Cancer Clinical samples. Hirief Proteomics

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

10

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data